Quercetin and Luteolin Improve the Anticancer Effects of 5-Fluorouracil in Human Colorectal Adenocarcinoma In Vitro Model: A Mechanistic Insight.

The aim of this study was to investigate the antitumor effects of quercetin and luteolin combined with 5-Fluorouracil (5-FU) in HT-29 human colorectal cancer cells. Cell viability induced by quercetin, luteolin and combination of these compounds with 5-FU were determined by MTT assay, also Cell deat...

Descripción completa

Detalles Bibliográficos
Publicado en:Nutrition & Cancer Vol. 74; no. 2; pp. 660 - 677
Autores principales: Erdoğan, Mehmet Kadir, Ağca, Can Ali, Aşkın, Hakan
Formato: pictorial research tables/charts Journal Article
Publicado: Taylor & Francis Ltd 2022
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=155436625&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 155436625
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        01635581
        7MS
      jtl: Nutrition & Cancer
      issn: 01635581
      maglogo: N
    pubinfo:
      dt: 2022
      vid: 74
      iid: 2
      pid: 377
      pub: Taylor & Francis Ltd
      place: Philadelphia, Pennsylvania
    artinfo:
      ui:
        155436625
        151575715
        155436625
        155436625
        10.1080/01635581.2021.1900301
        155436625
      ppf: 660
      ppct: 17
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Quercetin and Luteolin Improve the Anticancer Effects of 5-Fluorouracil in Human Colorectal Adenocarcinoma In Vitro Model: A Mechanistic Insight.
      aug:
        au:
          Erdoğan, Mehmet Kadir
          Ağca, Can Ali
          Aşkın, Hakan
        affil: Department of Biology, Faculty of Arts and Sciences, Bingol University, Bingol, Turkey
      sug:
        subj:
          Flavones Pharmacodynamics
          Quercetin Pharmacodynamics
          Colorectal Neoplasms Drug Therapy
          Adenocarcinoma Drug Therapy
          Fluorouracil Pharmacodynamics
          Antineoplastic Agents, Combined Pharmacodynamics
          Human
          In Vitro Studies
          Cell Line, Tumor Drug Effects
          Cell Viability Drug Effects
          Enzyme-Linked Immunosorbent Assay
          Apoptosis Drug Effects
          Microscopy Methods
          Molecular Structure
          Neovascularization, Pathologic
          Blotting, Western
          Polymerase Chain Reaction
          Vascular Endothelial Growth Factors Drug Effects
          Gene Expression Drug Effects
          Signal Transduction Drug Effects
          Descriptive Statistics
      ab: The aim of this study was to investigate the antitumor effects of quercetin and luteolin combined with 5-Fluorouracil (5-FU) in HT-29 human colorectal cancer cells. Cell viability induced by quercetin, luteolin and combination of these compounds with 5-FU were determined by MTT assay, also Cell death detection Elisa assay and fluorescence microscopy were performed to investigate apoptotic effects. Hu-VEGF Elisa assay was employed to determine the effects of treatments on angiogenesis. Western blot and qRT-PCR analysis were performed to investigate effects on p53, Bax, Bcl-2, p38 MAPK, mTOR, PTEN, and Akt proteins and genes. The results indicated that quercetin, luteolin and combinations of these compounds with 5-FU inhibited the growth of HT 29 cells. Compared to the control, apoptosis were triggered 8.1 and 10.1 fold in HT-29 cells, that treated with quercetin + 5-FU and luteolin + 5-FU, respectively. VEGF amount significantly decreased by combined treatments. qRT-PCR and western blot results demonstrated that quercetin, luteolin and the combinations of these flavonoids with 5-FU, modulate the apoptotic pathways in HT-29 cells. The increase in p53, Bax, p38 MAPK, and PTEN gene expression levels compared to the control group was 1.71, 1.42, 3.26, and 3.29-fold with 5-FU + L treatment, respectively, while this increase was 8.43, 1.65, 3.55, and 3.54-fold with 5-FU + Q treatment, respectively. In addition, when the anti-apoptotic Bcl-2, mTOR, and Akt gene expression levels were normalized as 1 in the control group, they were 0.28, 0.41, and 0.22 with 5-FU + L treatment, and 0.32, 0.46, and 0.39, respectively, with 5-FU + Q treatment. These findings suggested that quercetin and luteolin synergistically enhanced the anticancer effect of 5-FU in HT 29 cells and may therefore minimize the toxic effects of 5-FU in the clinical treatment of colorectal cancer.
      pubtype: Academic Journal
      doctype:
        pictorial
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N